ARCHIVES

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

This article is from The Cancer Letter archive.

Vol. 22 No. 04 | January 26, 1996

Download PDF Visit The Full Archive

Related Articles

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

January 27, 1989

The NLST at a Glance

August 2, 2013

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

In Brief: Livingston Completes Term On NCI Board, Appelbaum To Succeed Him as Chairman

November 12, 1999

Komen Foundation Awards New Grants

October 20, 1995